HOME >> MEDICINE >> NEWS
We weren't made to multitask

It's readily apparent that handling two things at once is much harder than handling one thing at a time. Spend too much time trying to juggle more than one objective and you'll end up wanting to get rid of all your goals besides sleeping. The question is, though, what makes it so hard to process two things at once?

Two theories try to explain this phenomenon: "passive queuing" and "active monitoring." The former says that information has to line up for a chance at being processed at some focal point of the brain, while the latter suggests that the brain can process two things at once it just needs to use a complicated mechanism to keep the two processes separate. Recent research from MIT points to the former as an explanation.

Yuhong Jiang, Rebecca Saxe and Nancy Kanwisher, in a study to be published in the June issue of Psychological Science, a journal of the American Psychological Society, examined the brain activity involved in multitasking. They gave people two simple tasks. Task one was identifying shapes, and for some subjects, task two was identifying letters, for others it was identifying colors. The subjects were forced to switch from one task to the other in either one and a half seconds or one tenth of a second. When they had to switch faster, subjects would take as much as twice as long to respond than when switching more slowly.

Using MRI technology, Jiang, Saxe and Kanwisher examined subjects' brain activity while performing these tasks. They observed no increase in the sort of activity that would be involved in keeping two thought processes separate when subjects had to switch faster. This suggests that there are no complicated mechanisms that allow people to perform two tasks at once. Instead, we have to perform the next task only after the last one is finished.


'"/>

Contact: Yuhong Jiang
yuhong@wjh.harvard.edu
Association for Psychological Science
7-Jun-2004


Page: 1

Related medicine news :

1. News briefs from the journal CHEST, March 2005
2. LA BioMed medical/research briefs March 2005
3. News briefs from the journal CHEST, February 2005
4. LA BioMed medical/research briefs January 2005
5. News briefs from the journal Chest, January 2005
6. LA BioMed Medical/Research briefs January 2005
7. News briefs from the Journal CHEST, December 2004
8. News briefs from the Journal CHEST, November 2004
9. LA BioMed research briefs
10. News briefs from the journal Chest, October 2004
11. News briefs from the journal CHEST, May 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... ... been officially recognized for its September 2016 donation of dog beds to the ... received three awards and honors for its contribution from city and state officials. ...
(Date:9/19/2017)... ... 2017 , ... Public outrage over the toxins that exist in tap water ... the water industry itself to research, develop and ultimately supply consumers with healthy drinking ... field of natural alkaline water technologies, water filtration systems, and ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. , ACPG ... El Naturalista is a trusted, well-respected brand reliant on the healing properties of ...
(Date:9/19/2017)... PETALUMA, Calif (PRWEB) , ... ... ... Tripp, DVM, MS, DACVIM, a board-certified veterinary oncologist, has agreed to serve ... SNOA, warrants SNOAW). Dr. Tripp is founder of the Bridge Animal ...
(Date:9/19/2017)... ... 19, 2017 , ... Premiere Long Island dental office Gold Coast Smiles is ... the best dentists in America under age 40 by Incisal Edge magazine. , ... magazine features the best 40 dentists under the age of 40 renowned for medical ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... Sept. 5, 2017 Sapheneia and Scannerside received ... Scannerside DoseCheck is a third-party Vendor neutral CT product ... and allows compliance with current MITA standards. ... 29 DoseCheck solution is specifically designed to provide CT ... potential radiation doses over a predefined threshold. Scannerside Dose ...
Breaking Medicine Technology:
Cached News: